Delcath Systems (DCTH) Cash from Investing Activities (2010 - 2026)
Delcath Systems (DCTH) recorded quarterly Cash from Investing Activities of -$571000.0 in Q1 2026, down 1.78% quarter-over-quarter from -$561000.0 in Q4 2025, and up 97.73% on a YoY basis from -$288778.4 in Q1 2025.
Delcath Systems (DCTH) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Delcath Systems' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$571000.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 97.73% year-over-year to -$571000.0; the TTM figure through Mar 2026 stood at -$2.0 million (up 93.46% YoY), while the FY2025 annual figure was -$26.6 million, down 2610.5% from the prior year.
- Cash from Investing Activities was -$571000.0 for Q1 2026 at Delcath Systems, down from -$561000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $10.3 million in Q2 2024 to a low of -$25.1 million in Q1 2025.
- Historically, Cash from Investing Activities has averaged -$3.2 million across 5 years, with a median of -$415000.0 in 2025.
- Biggest YoY gain for Cash from Investing Activities was 25810.0% in 2024; the steepest drop was 69800.0% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$68000.0 in 2022, then tumbled by 28826.47% to -$19.7 million in 2023, then grew by 22.58% to -$15.2 million in 2024, then jumped by 96.32% to -$561000.0 in 2025, then fell by 1.78% to -$571000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$571000.0 (Q1 2026), -$561000.0 (Q4 2025), and -$466000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Delcath Systems | 422.53 Mn | 333.22 Mn | 21.26 Mn | -571,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -571,000.00 |
| Mar 31, 2026 | -571,000.00 |
| Dec 31, 2025 | -561,000.00 |
| Dec 31, 2025 | -561,000.00 |
| Sep 30, 2025 | -466,000.00 |
| Sep 30, 2025 | -466,000.00 |
| Jun 30, 2025 | -415,000.00 |
| Jun 30, 2025 | -415,000.00 |
| Mar 31, 2025 | -25.15 Mn |
| Mar 31, 2025 | -25.15 Mn |
| Dec 31, 2024 | -15.23 Mn |
| Dec 31, 2024 | -15.23 Mn |
| Sep 30, 2024 | -697,000.00 |
| Sep 30, 2024 | -697,000.00 |
| Jun 30, 2024 | 10.28 Mn |
| Jun 30, 2024 | 10.28 Mn |
| Mar 31, 2024 | 4.66 Mn |
| Mar 31, 2024 | 4.66 Mn |
| Dec 31, 2023 | -19.67 Mn |
| Dec 31, 2023 | -19.67 Mn |